Trial Profile
A study investigating the effect of zotarolimus eluting stent in diabetic and Non-diabetic patients from a Italian multicenter registry with significant coronary artery stenosis who were suitable for Percutaneous Coronary Revascularization
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- 17 Dec 2015 New trial record